BMRN
#802
BioMarin Pharmaceutical Inc. - Common Stock
65.2 9 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.49%
Monthly Change
+5.19%
6 month change
+7.54%
Year Change
+13.47%
Previous Close
65.6 1
Open
65.2 9
Low
65.2 9
High
65.2 9
Volume
147
Financials
- Market Capitalization 12.64 B
- Employee 3 221
- Founded N/A
- CEO Alexander Hardy
- Website www.biomarin.com
- Headquarter Delaware, United States
- FIGI BBG000CZWZ05
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
33.02
Price to sales ratio
3.64
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 700 |  BBIO BridgeBio Pharma, Inc. - Common Stock | 78.68 USD | -0.87% | -5.08% | -7.02% | +38.04% | 15.38 B USD | ||
| 757 |  EXEL Exelixis, Inc. - Common Stock | 55.26 USD | -1.50% | +2.83% | -2.11% | +41.55% | 13.69 B USD | ||
| 803 |  CORT Corcept Therapeutics Incorporated - Common Stock | 116.93 USD | -2.40% | -3.75% | +23.08% | +59.37% | 12.64 B USD | ||
| 806 |  MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 543.69 USD | +0.89% | +3.94% | +0.39% | +28.35% | 12.56 B USD |
Frequently asked questions about BioMarin Pharmaceuticals Inc
What is the BioMarin Pharmaceuticals Inc stock price today?
The current price of BioMarin Pharmaceuticals Inc (BMRN) is 65.29. Over the past 24 hours, the stock has changed by -0.49%. Follow the BMRN chart for real-time price dynamics.
What is the stock ticker of BioMarin Pharmaceuticals Inc?
BioMarin Pharmaceuticals Inc trades under the ticker BMRN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is BioMarin Pharmaceuticals Inc stock going up?
BMRN has changed by -3.35% over the last week, +5.19% over the last month, and +13.47% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of BioMarin Pharmaceuticals Inc?
BioMarin Pharmaceuticals Inc currently has a market capitalization of 12.64 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were BioMarin Pharmaceuticals Inc earnings last quarter?
Last quarter, BioMarin Pharmaceuticals Inc reported earnings of 0.23 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was BioMarin Pharmaceuticals Inc revenue for the last quarter?
BioMarin Pharmaceuticals Inc reported quarterly revenue of 989.71 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was BioMarin Pharmaceuticals Inc net income for the last quarter?
BioMarin Pharmaceuticals Inc reported net income of 44.76 M for the last quarter. The previous quarter showed 105.53 M, which means net income changed by -57.58%.
How many employees does BioMarin Pharmaceuticals Inc have?
As of the latest available data, BioMarin Pharmaceuticals Inc has 3 221 employees. Workforce size can provide additional context about the company's scale and operations.
What is BioMarin Pharmaceuticals Inc EBITDA?
BioMarin Pharmaceuticals Inc EBITDA is 208.56 M, and its EBITDA margin is 21.07%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy BioMarin Pharmaceuticals Inc stock?
You can buy BioMarin Pharmaceuticals Inc (BMRN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in BioMarin Pharmaceuticals Inc stock?
Investing in BioMarin Pharmaceuticals Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BMRN chart and related analysis on metatrader.com as part of your research.